HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

dysprosium DTPA

RN given refers to di-Na salt; RN for parent cpd not available 6/88

Also Known As:

Dy(DTPA)2-; Dy-DTPA

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133

Experts

1.	Mattrey, Robert F: 1 article (07/2002)
2.	Vera, David R: 1 article (07/2002)

Related Diseases

1.	Stroke (Strokes) 09/01/1996 - "In this rat stroke model, dysprosium DTPA BMA and the superparamagnetic iron oxide particles NSR 0430 were found to be equally efficacious for the diagnosis of the perfusion deficit, but if safe for human investigations, iron oxide particles would have an advantage as equal susceptibility effect may be achieved with smaller injection volumes." 09/01/1993 - "The same multisection methods were used to track the first-pass transit of a bolus of dysprosium-DTPA-BMA [diethylenetriaminepentaacetic acid-bis(methylamide)] to assess relative tissue perfusion before and after stroke and after treatment with a thrombolytic agent. "
2.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/01/1996 - "In seven rats subjected to middle cerebral artery occlusion, two dynamic MR perfusion imaging series were acquired after intravenous bolus injections of .5 mmol/kg dysprosium DTPA BMA and .06 mmolFe/kg iron oxide particles, respectively. "
3.	Neoplasms (Cancer) 07/01/2002 - "One rabbit with a VX2 tumor was imaged with [Dy]DTPA-dextran (0.5 mL, 3.1 g, 1.15 mmol of dysprosium per kilogram). "
4.	Myocardial Infarction 12/01/1992 - "Delineation of acute myocardial infarction with dysprosium DTPA-BMA: influence of dose of magnetic susceptibility contrast medium."
5.	Brain Ischemia (Cerebral Ischemia) 09/01/1996 - "Comparison of dysprosium DTPA BMA and superparamagnetic iron oxide particles as susceptibility contrast agents for perfusion imaging of regional cerebral ischemia in the rat."

Related Drugs and Biologics

1.	Fibrinolytic Agents (Antithrombotic Agents)
2.	Dysprosium
3.	Dextrans (Dextran)
4.	Contrast Media
5.	Acids
6.	NSR 0430
7.	ferric oxide (iron oxide)

Related Therapies and Procedures

1.	Injections
2.	Aftercare (After-Treatment)